drugset / Trial / NCT00210873
An Open Label Extension of a Study of Topiramate in Chronic Migraine.
Phase 3
Completed
200 enrolled
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ortho-McNeil Neurologics, Inc. · collab
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the long-term safety and effectiveness of topiramate for the prevention of headaches in adults with chronic migraine. Topiramate has been approved to prevent migraine headaches.
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | — | Oral |